Anti-Osteoprotegerin antibody
Be the first to review this product! Submit a review
|
(16 Publications)
Rabbit Polyclonal Osteoprotegerin antibody. Suitable for WB and reacts with Human samples. Cited in 16 publications. Immunogen corresponding to Synthetic Peptide within Mouse Tnfrsf11b aa 200-300 conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
OCIF, OPG, TNFRSF11B, Tumor necrosis factor receptor superfamily member 11B, Osteoclastogenesis inhibitory factor, Osteoprotegerin
- WB
Supplier Data
Western blot - Anti-Osteoprotegerin antibody (AB203061)
All lanes:
Western blot - Anti-Osteoprotegerin antibody (ab203061) at 1/1000 dilution
Lane 1:
Human Raji cell lysate
Lane 2:
Human U251 cell lysate
Secondary
All lanes:
Conjugated Secondary at 1/20000 dilution
Predicted band size: 46 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OPG inhibits the differentiation and activation of osteoclasts by binding to RANKL preventing its interaction with the receptor RANK on the surface of osteoclast progenitor cells. As part of a non-classical signaling pathway OPG plays a significant role in the regulation of bone remodeling and maintenance by controlling bone resorption. This activity preserves bone density and structure by limiting excessive osteoclastic activity.
Pathways
OPG operates within the RANK/RANKL/OPG signaling axis which is important for bone metabolism. It counteracts the bone-resorption pathway driven by the RANKL-RANK interaction inhibiting osteoclastogenesis. This axis involves interactions with other proteins such as RANK RANKL and TRAIL where TRAIL’s involvement hints towards a broader immune regulation role for OPG.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in bioengineering and biotechnology 13:1555983 PubMed40599407
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical medicine 14: PubMed39941567
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 25:78 PubMed39819670
2025
Applications
Unspecified application
Species
Unspecified reactive species
Progress in orthodontics 25:45 PubMed39581932
2024
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:280 PubMed37500654
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutical biology 61:391-403 PubMed36740874
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 26:4032-4047 PubMed35726597
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:710169 PubMed34552485
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34502380
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:768 PubMed34268381
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com